Smaller biotechs hit as Shire cuts bait on experimental drugs
Amicus Therapeutics announced a work-force reduction of about 20 percent, or 26 employees, as a part of a corporate restructuring after a commercialization deal with Shire soured.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.